Effects of 0.01%Atropine Eye Drops on Horizontal Meridian Choroidal Thickness Profile in Low to Moderate Myopic Children  

作　　者：Yun Tang Xufei Chen Xiaofeng Deng Junna Zhang Liping Liu Chixin Du 

机构地区：[1]Department of Ophthalmology,The Fourth Affiliated Hospital,Zhejiang University School of Medicine,Jinhua 322000,Zhejiang,China [2]State Key Laboratory of Modern Optical Instrumentation,College of Optical Science and Engineering,Zhejiang University,Hangzhou 310058,Zhejiang,China [3]Department of Ophthalmology,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310000,Zhejiang,China

出　　处：《Journal of Clinical and Nursing Research》2025年第4期256-264,共9页临床护理研究(英文)

基　　金：Education Department of Zhejiang Province(Project No.:201942041);the Health Commission of Zhejiang Province(Project No.:W20008);the Science and Technology program of Jinhua Science and Technology Bureau(Project No.:2020-4-106).

摘　　要：Purpose:To examine the changes in choroidal thickness(ChT)after 6-month topical treatment of 0.01%atropine eye drops in myopic children.Methods:A total of 46 low to moderate myopic children aged 8 to 12 years were recruited and received topical 0.01%atropine once a day for 6 months.Spherical equivalent(SE),axial length(AL),and ChT were measured at baseline,3 months,and 6 months.Results:During the first and second 3-month treatment,there is no significant decrease in progression of SE and AL.Within the range of 3 mm from the temporal side of the fovea to the nasal side,no significant changes in ChT have been observed at any measuring points in low and moderate myopic participants.Changes in ChT were not significantly associated with gender or AL progression.Conclusion:A 6-month topical treatment of 0.01%atropine could not cause significant changes in ChT in myopic children.

关 键 词：Atropine Choroidal thickness Children Myopia controlling 

分 类 号：R778.1[医药卫生—眼科]